Ribo-seq rRNA reads reveal co-predicted signatures of ribosome heterogeneity and collisions
Briefings in Bioinformatics · 2026
DOI: 10.1093/bib/bbag575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Edwin S Kyei-Baffour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: RNA, Ribosomal, Ribosomes, Computational Biology, Sequence Analysis, RNA. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch Research Council, The Dutch Cancer Society, Dutch Ministry of Health, Welfare and Sport.
Abstract (Originalsprache)
Ribosome heterogeneity is increasingly recognized as a key factor in various biological contexts, including development, cancer, and immune responses. To enable systematic exploration of this diversity, we previously developed a bioinformatics method that utilized rRNA reads from Ribo-seq data, detecting changes in ribosomal protein composition (dripARF) and ribosome collisions (dricARF) between conditions simply and efficiently. The method works by projecting differences in rRNA read abundance onto the 3D-structure of the ribosome, following which we perform enrichment tests on predefined heterogeneity-specific rRNA position sets. In this study, we apply this tool to publicly available Ribo-seq datasets to understand the impact of experimental protocol variations and to identify shared biological signals across studies. Our analyses show that the rRNA regions assigned to our prediction sets are consistently enriched in rRNA reads, supporting the core assumptions of our approach. We further examine how various protocol factors influence rRNA read distribution and implement a single-sample rRNA position set enrichment analysis-based weight to limit false positives. Finally, we highlight consistent ribosomal changes across these studies, including prominent co-predictors such as ribosome collisions, eS25, and uS19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
- Oncode Institute, Jaarbeursplein 6, 3521AL, Utrecht, The Netherlands.
- School of Biochemistry and Biomedical Science, University of Bristol, University Walk, Clifton, Bristol, BS8 1TD, United Kingdom.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS, Utrecht, The Netherlands.
ORCID-Profile: Edwin S Kyei-Baffour, William J Faller, Ferhat Alkan
Förderung
- Dutch Research Council
- The Dutch Cancer Society
- Dutch Ministry of Health, Welfare and Sport
Zitieren
APA
Kyei-Baffour, E. S., Faller, W. J., & Alkan, F. (2026). Ribo-seq rRNA reads reveal co-predicted signatures of ribosome heterogeneity and collisions. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbag575
Vancouver
Kyei-Baffour ES, Faller WJ, Alkan F. Ribo-seq rRNA reads reveal co-predicted signatures of ribosome heterogeneity and collisions. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbag575
BibTeX
@article{KyeiBaffour2026,
author = {Kyei-Baffour, Edwin S and Faller, William J and Alkan, Ferhat},
title = {Ribo-seq rRNA reads reveal co-predicted signatures of ribosome heterogeneity and collisions},
journal = {Briefings in Bioinformatics},
year = {2026},
doi = {10.1093/bib/bbag575}
}
EUVIMED